- The Department of Cancer Immunology and AIDS at Dana-Farber is changing its name to the Department of Cancer Immunology and Virology.
Tags: BasicResearch, Immunotherapy
- Before you fire up the backyard grill this summer, review these tips from Dana-Farber Cancer Institute experts to help reduce your exposure to potentially cancer causing chemicals.
Tags: Nutrition, Prevention
- Dana-Farber Cancer Institute and Eli Lilly and Company announced a multiyear collaboration to research new medicines under development to fight cancer.
Tags: BasicResearch, Partnerships
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center remains the nation's top pediatric cancer program, according to the 2015-16 edition of U.S. News & World Report's Best Children's Hospitals.
- Dana-Farber's Molecular Cancer Imaging Facility in Boston's Innovation District will use cutting edge technology for research on improving cancer diagnosis and developing precision drugs matched to individual patients.
Tags: BasicResearch, Imaging
- Study led by Dr. Jennifer Ligibel finds exercise programs can improve quality of life for cancer survivors.
Tags: BreastCancer, Nutrition
- In a new study published in Nature, Dana-Farber scientists demonstrate how a sudden, isolated shuffling of genetic material — known as chromothripsis — can occur.
Tags: BasicResearch, Genomics
- On June 1st, Dana-Farber Community Cancer Care (DFCCC) will begin providing oncology services at Holy Family Hospital in Methuen.
- A new technology developed at Dana-Farber may make it possible to target "undruggable" proteins and overcome drug resistance by using a cancer cell's own protein-degrading machinery to destroy, not just inhibit, cancer proteins.
Tags: BasicResearch, TargetedTherapy
- First study of the genomic composition of prostate cancer shows many patients have gene mutations that can be targeted with existing or potential drugs.
Tags: Genomics, ProstateCancer, TargetedTherapy
Showing 1-10 of 606 items